Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra D'Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez-Canales, Alexander J. Lazar, Ignacio I. WistubaLaurence H. Baker, Robert G. Maki, Denise Reinke, Shreyaskumar Patel

Research output: Contribution to journal › Article › peer-review

374 Scopus citations

Fingerprint

Dive into the research topics of 'Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences